http://purl.org/np/RA5oK7bpcr... RA5oK7bpcr

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#type type

http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement Statement

Leoni Bücken

2021-08-23T16:41:12.827Z

http://purl.org/np/RA5oK7bpcr... RA5oK7bpcr

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/2000/01/rdf-schema#label label

"Administration of Mifepristone tablets, 200mg and misoprostol for the termination of pregnancy (the ""treatment procedure"") is contraindicated in patients with any of the following conditions: - [ see Warnings and Precautions ( 5.4 - - - [ see Adverse Reactions ( 6.2 - - Use of Mifepristone tablets, 200mg and misoprostol for termination of intrauterine pregnancy is contraindicated in patients with an intrauterine device (""IUD"") in place (the IUD might interfere with pregnancy termination). If the IUD is removed, Mifepristone tablets, 200mg may be used. Confirmed/suspected ectopic pregnancy or undiagnosed adnexal mass ( 4 Chronic adrenal failure ( 4 Concurrent long-term corticosteroid therapy ( 4 History of allergy to mifepristone, misoprostol, or other prostaglandins ( 4 Hemorrhagic disorders or concurrent anticoagulant therapy ( 4 Inherited porphyria ( 4 Intrauterine device (IUD) in place ( 4"

Leoni Bücken

2021-08-23T16:41:12.827Z

http://purl.org/np/RA5oK7bpcr... RA5oK7bpcr

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#object object

http://purl.obolibrary.org/obo/DOID_0060329 DOID_0060329

Leoni Bücken

2021-08-23T16:41:12.827Z

http://purl.org/np/RA5oK7bpcr... RA5oK7bpcr

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate predicate

https://w3id.org/biolink/vocab/treats treats

Leoni Bücken

2021-08-23T16:41:12.827Z

http://purl.org/np/RA5oK7bpcr... RA5oK7bpcr

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

http://www.w3.org/1999/02/22-rdf-syntax-ns#subject subject

https://identifiers.org/drugbank:DB00834 drugbank:DB00834

Leoni Bücken

2021-08-23T16:41:12.827Z

http://purl.org/np/RA5oK7bpcr... RA5oK7bpcr

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/provided_by provided_by

https://w3id.org/um/NeuroDKG NeuroDKG

Leoni Bücken

2021-08-23T16:41:12.827Z

http://purl.org/np/RA5oK7bpcr... RA5oK7bpcr

links a nanopublication to its assertion http://www.nanopub.org/nschema#hasAssertion assertion

https://w3id.org/biolink/vocab/relation relation

https://schema.org/MedicalContraindication MedicalContraindication

Leoni Bücken

2021-08-23T16:41:12.827Z